Intratympanic plus systemic corticosteroids (combined therapy) vs systemic corticosteroids alone
Final hearing threshold determined by PTA (a lower value represents better hearing) · sudden sensorineural hearing loss
It is very uncertain whether intratympanic plus systemic corticosteroids (combined therapy) changes final hearing threshold determined by PTA A lower value represents… compared with systemic corticosteroids alone (very low certainty).
2 findings from 1 review
- Intratympanic corticosteroids for sudden sensorineural hearing loss 2022 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 194 participantsVery low
- Intratympanic corticosteroids for sudden sensorineural hearing loss 2022 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found